Premium
P4‐278: ALTERED FECAL MICROBIOTA COMPOSITION IN CHINESE PATIENTS WITH ALZHEIMER'S DISEASE
Author(s) -
Peng Guoping
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.07.100
Subject(s) - gut flora , ruminococcus , feces , biology , dysbiosis , relative species abundance , microbiome , alzheimer's disease , clostridium , dementia , abundance (ecology) , disease , physiology , immunology , medicine , microbiology and biotechnology , ecology , bioinformatics , bacteria , genetics
associative trend with improvements in NPI-A/A with nabilone compared to placebo (b1⁄4-5.3, 95% -11.02 to 0.35, p1⁄40.065). Increases in Cchol levels from BL had an associative trend with a reduction in NPI-A/A with nabilone compared to placebo (b1⁄44.0, 95% -8.24 to 0.27, p1⁄40.067). In thosewith minimal to marked improvement on the CGIC during nabilone (N1⁄417), increases in Cchol levels from BL were significantly associated with a reduction in NPI-A/A in nabilone compared to placebo (b1⁄4-8.1, 95% CI -12.7 to -3.5, p1⁄40.001). Conclusions: These findings suggest that serum Cchol may be a marker of agitation severity in AD, and a marker of treatment response to nabilone.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom